Relapsed and refractory acute lymphoblastic leukaemia in children

What changed: Relapsed and refractory acute lymphoblastic leukaemia in children

Every dated change on the records linked to Relapsed and refractory acute lymphoblastic leukaemia in children, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Trial result3Milestone6This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-17This recordRelapsed and refractory acute lymphoblastic leukaemia in children
Facts on this page last checked
When this page itself was last checked or edited.

2024 · 3

2021 · 1

2021MilestoneBlinatumomab
AALL1331 and IntReALL: blinatumomab beats chemotherapy in first relapse
A milestone in how this cancer is treated.

2018 · 2

2017 · 1

2017MilestoneTisagenlecleucel
Tisagenlecleucel approved: the first CAR T-cell therapy for any cancer, for children and young adults with relapsed B-ALL
A milestone in how this cancer is treated.

2014 · 1

2014MilestoneBlinatumomab
Blinatumomab approved for relapsed or refractory B-ALL in adults
A milestone in how this cancer is treated.

2010 · 1

2010MilestoneMitoxantrone
UKALLR3: mitoxantrone reinduction nearly doubles progression-free survival in relapsed childhood ALL
A milestone in how this cancer is treated.